Abstract
The main goal of the treatment of the head and neck cancers is to maintain the important functions such as voice, swallowing, hearing, smell, taste and look, and to keep the quality of life of the patients. For this purpose, the concurrent chemo-radiotherapy utilizing 5-FU and vitamin A (FAR regimen) has been used in the author's department. With the FAR therapy regimen, the disease-specific five year survival rate was satisfactory in head and neck cancer. Especially, the overall disease-specific five year survival rate of the laryngeal cancer (glottic type) was 92.6%. Thus, FAR regimen may play an important role in the improved survival rate, organ preservation and the quality of life of the patients.
